Increased Mucosal IL-22 Production of an IL-10RA Mutation Patient Following Anakinra Treatment Suggests Further Mechanism for Mucosal Healing

View/ Open
Published Version
https://doi.org/10.1007/s10875-016-0365-3Metadata
Show full item recordCitation
Li, Jian, Dror S. Shouval, Andria L. Doty, Scott B. Snapper, and Sarah C. Glover. 2017. “Increased Mucosal IL-22 Production of an IL-10RA Mutation Patient Following Anakinra Treatment Suggests Further Mechanism for Mucosal Healing.” Journal of Clinical Immunology 37 (2): 104-107. doi:10.1007/s10875-016-0365-3. http://dx.doi.org/10.1007/s10875-016-0365-3.Other Sources
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5325838/pdf/Terms of Use
This article is made available under the terms and conditions applicable to Other Posted Material, as set forth at http://nrs.harvard.edu/urn-3:HUL.InstRepos:dash.current.terms-of-use#LAACitable link to this page
http://nrs.harvard.edu/urn-3:HUL.InstRepos:32072038
Collections
- HMS Scholarly Articles [17730]
Contact administrator regarding this item (to report mistakes or request changes)